Edition:
India

Collplant Holdings Ltd (CLGN.OQ)

CLGN.OQ on NASDAQ Stock Exchange Capital Market

6.00USD
13 Apr 2018
Change (% chg)

-- (--)
Prev Close
$6.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$10.19
52-wk Low
$5.22

Summary

Name Age Since Current Position

David Tsur

67 2018 Chairman of the Board

Yehiel Tal

64 2010 Chief Executive Officer

Talya Zavchon

32 2017 Finance Director

Oded Shoseyov

60 2016 Chief Scientific Officer

Eran Rotem

49 2012 Vice President - Finance

Ilana Belzer

57 2015 Vice President - Operations

Philippe Bensimon

51 2011 Vice President-Regulation & Quality Control

Nadav Orr

59 2014 Vice President - Research & Development

Shomrat Shurtz

50 2015 Vice President - Commercialization

Dana Gottesman Erlich

42 2013 Internal Auditor

Revital Mandil-Levin

2018 Chief Business Development Officer

Adi Goldin

43 2018 Director

Gili Hart

42 2017 External Director

Elan Penn

66 2018 External Director

Scott Burell

53 2017 Independent Director

Abraham Havron

70 2016 Independent Director

Biographies

Name Description

David Tsur

Mr. David Tsur has been appointed Chairman of the Board at Collplant Holdings Ltd effective January 14, 2018. Until this date, he served as Director at the Company from March 15, 2017. His work experience includes the following roles: Co-Founder, Chief Executive Officer, Deputy Chairman of the Board and Director of Kamada, Chief Executive Officer of Arad Systems and RAD Chemicals Inc and has held various positions in the Israeli Ministry of Economy (formerly named the Ministry of Industry and Trade), including Chief Economist and Commercial Attaché in Argentina and Iran. He holds a Bachelors degree in Economics and International Relations and a MBA degree, both from The Hebrew University of Jerusalem.

Yehiel Tal

Mr. Yehiel Tal serves as Chief Executive Officer at Collplant Holdings Ltd since May 20, 2010. Previously, he served as Chief Executive Officer at Rigentis BioMaterials Ltd. Mr. Tal holds a Master of Engineering degree in Mechanical Engineering from the Technion - Israel Institute of Technology.

Talya Zavchon

Ms. Talya Zavchon serves as Finance Director at Collplant Holdings Ltd since February 9, 2017. She also serves as Finance Director at the Company's subsidiary, Collplant Ltd. She holds a Bachelors degree in Accounting and Economics from Ben Gurion University. She is a Certified Chartered Accountant.

Oded Shoseyov

Prof. Oded Shoseyov serves as Chief Scientific Officer at Collplant Holdings Ltd since May 20, 2010 and no longer serves as Director at the Company effective October 14, 2016. He has held the role of Director from May 20, 2010. He is the founder of the Company. He holds a Doctorate of Science degree in Biochemistry from The Hebrew University of Jerusalem.

Eran Rotem

Mr. Eran Rotem serves as Vice President - Finance at Collplant Holdings Ltd since January 15, 2012. He also serves as Vice President - Finance at Collplant Ltd (a wholly-owned subsidiary of the firm). His work experience includes the following roles: Vice President - Finance at Tefron Ltd (2008-2011) and Vice President - Finance at Healthcare Technologies Ltd (part of Gamida for Life BV group; 2002-2008). He holds a Bachelor of Business Administration degree, majoring in Accounting, from Hamichlala Leminhal. He is a Certified Public Accountant.

Ilana Belzer

Dr. Ilana Belzer serves as Vice President - Operations at Collplant Holdings Ltd since October 6, 2015. Her work experience includes the following roles: Chief Operating Officer at Innovative Biotechnology Company (2012-2015), Vice President Research & Development & Operations at Procognia Ltd. (2008-2012) and Plant Manager at Omrix Biopharmaceuticals (2004-2008). Dr. Belzer holds a Master of Science degree in Microbiology and a Doctorate of Science degree in Cellular Biology, both from Tel Aviv University.

Philippe Bensimon

Dr. Philippe David Bensimon serves as Vice President-Regulation and Quality Control at Collplant Holdings Ltd and at its subsidiary (Collplant Ltd) since December 1, 2011. His work experience includes the role of Director of Regulation and Quality Control at Maquet-Getinge for six years. Dr. Bensimon holds a Doctorate of Science degree in Pharmacy from Aix-Marseille University, France.

Nadav Orr

Dr. Nadav Orr serves as Vice President - Research & Development at Collplant Holdings Ltd since September 7, 2014. His work experience includes the following roles: Associate Director, Research and Development at Omrix Biopharmaceuticals Ltd, a subsidiary of Ethicon Biosurgery, Johnson & Johnson (2012-August 2014) and Projects Manager at Omrix Biopharmaceuticals Ltd, (2005-2012). Dr. Orr holds a Bachelor of Science degree in Biology from The Hebrew University of Jerusalem and a Master of Science degree in Biological Chemistry and a Doctorate of Science degree in Immunology, both from Weizmann Institute of Science, Israel.

Shomrat Shurtz

Ms. Shomrat Shurtz serves as Vice President - Commercialization at Collplant Holdings Ltd since September 20, 2015. Her work experience includes the role of Senior Director of Lysosomal Therapeutic Products-Israeli Market at Protalix Biotherapeutics Inc (2008-2015). She holds a Bachelor of Science degree and a Master of Science degree in Life Sciences, both from Tel Aviv University.

Dana Gottesman Erlich

Ms. Dana Gottesman Erlich serves as Internal Auditor at Collplant Holdings Ltd since November 27, 2013. Her work experience includes the roles of Internal Auditor at Safe-T Group Ltd and Manager at BDO Ziv Haft Accountancy firm (over five years). She holds a Bachelor of Business Administration degree from Hamichlala Leminhal and a Masters degree in Public Management from Bar Ilan University. She is a Certified Chartered Accountant.

Revital Mandil-Levin

Dr. Revital Mandil-Levin has been appointed Chief Business Development Officer at Collplant Holdings Ltd effective April 12, 2018. Her work experience includes the following roles: Vice President Business Development at NeuroDerm Ltd (January 2014-February 2018), Vice President Business Development at HealOr Ltd (2004-2013) and Business Development Manager at Proteologics Ltd (until 2004). Dr. Mandil-Levin holds a Doctorate of Science degree in Biochemistry from Bar Ilan University and a MBA degree from Tel Aviv College of Management.

Adi Goldin

Mr. Adi Goldin serves Director at Collplant Holdings Ltd since May 20, 2010. He is a member of the Finance and Identification committees. During June 24, 2016 and January 14, 2018, he has served as Temporary Chairman of the Board at the Company. His work experience includes the following roles: Lawyer, Vice President at Docor International Management Ltd, Chief Executive Officer at Softlib Ltd and Director at a variety of companies. He holds a LLB degree, a Bachelors degree in Economics and a Masters degree in Economics, all from Tel Aviv University.

Gili Hart

Dr. Gili Hart has been appointed External Director at Collplant Holdings Ltd effective July 4, 2017. Her work experience includes the following roles: Chief Executive Officer at OPKO Biologics (from 2014) and Vice President Pre-clinic and Clinic Pharmacology at Prolor Biotech Ltd (2011-2014). Dr. Hart holds a Bachelor of Science degree in Biotechnology from The Technion – Israel Institute of Technology and a Master of Science degree and a Doctorate of Science degree, both in Immunology from Weizmann Institute of Science.

Elan Penn

Dr. Elan Penn has been appointed External Director at Collplant Holdings Ltd effective January 14, 2018. His work experience includes the following roles: Chief Executive Officer and Chairman at Penn Publications Ltd (since 2001) and Director and various committees member at Magic Software Enterprises Ltd. Dr. Penn holds a Bachelors degree in Economics and a Doctorate in Philosophy degree in Management Science from Imperial College, London.

Scott Burell

Mr. Scott R. Burell has been appointed Independent Director at Collplant Holdings Ltd effective October 2, 2017. His work experience includes the role of Chief Financial Officer at Combimatrix Corporation from 2006. He holds a Bachelors degree in Accounting and a Bachelor of Business Administration degree, both from Central Washington University. He is a Certified Public Accountant.

Abraham Havron

Dr. Abraham (Avri) Havron serves as Independent Director at Collplant Holdings Ltd since May 20, 2016. He is a member of the Compensation, Identification and Financial Statements Auditing committees. His work experience includes the following roles: Director at Kamada Ltd. (from 2011) and Director and Chief Executive Officer at Prolor Biotech Inc. (2005-2013). Dr. Havron holds a Bachelor of Science degree in Chemistry and Physics and a Master of Science degree in Organic Chemistry, both from The Hebrew University of Jerusalem and a Doctorate of Science degree in Biochemistry from Weizmann Institute of Science.